BIOMEDITECH ApS: Financial statements 2015
CVR: 34707847
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
BIOMEDITECH ApS (CVR 34707847) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 35 the year before. Equity in the 2015 report amounted to DKK 124,282. The solvency ratio was 99.4%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 124,282
- Total Assets
- DKK 125,000
Official annual report
How creditworthy is BIOMEDITECH ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
BIOMEDITECH ApS has published its annual report for 2014. Revenue came to DKK 0, and the net result was DKK 35.
On January 25, 2015, the company changed its name from DRUG TESTING EUROPE ApS to BIOMEDITECH ApS.
About BIOMEDITECH ApS
BIOMEDITECH ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2012. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named DRUG TESTING EUROPE ApS. The management consists of Tobias Chalmer Stahl Rasmussen. The company is owned by Chalmer Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 106,895 and a net result of DKK -6,298 compared with DKK 290,046 the year before. Equity in the 2025 report amounted to DKK 877,884.